Genetic loss of AMPK-glycogen binding destabilises AMPK and disrupts metabolism

Objective: Glycogen is a major energy reserve in liver and skeletal muscle. The master metabolic regulator AMP-activated protein kinase (AMPK) associates with glycogen via its regulatory β subunit carbohydrate-binding module (CBM). However, the physiological role of AMPK-glycogen binding in energy h...

Full description

Bibliographic Details
Main Authors: Nolan J. Hoffman, Jamie Whitfield, Natalie R. Janzen, Mehdi R. Belhaj, Sandra Galic, Lisa Murray-Segal, William J. Smiles, Naomi X.Y. Ling, Toby A. Dite, John W. Scott, Jonathan S. Oakhill, Robert Brink, Bruce E. Kemp, John A. Hawley
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:Molecular Metabolism
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2212877820301228
_version_ 1811324747855691776
author Nolan J. Hoffman
Jamie Whitfield
Natalie R. Janzen
Mehdi R. Belhaj
Sandra Galic
Lisa Murray-Segal
William J. Smiles
Naomi X.Y. Ling
Toby A. Dite
John W. Scott
Jonathan S. Oakhill
Robert Brink
Bruce E. Kemp
John A. Hawley
author_facet Nolan J. Hoffman
Jamie Whitfield
Natalie R. Janzen
Mehdi R. Belhaj
Sandra Galic
Lisa Murray-Segal
William J. Smiles
Naomi X.Y. Ling
Toby A. Dite
John W. Scott
Jonathan S. Oakhill
Robert Brink
Bruce E. Kemp
John A. Hawley
author_sort Nolan J. Hoffman
collection DOAJ
description Objective: Glycogen is a major energy reserve in liver and skeletal muscle. The master metabolic regulator AMP-activated protein kinase (AMPK) associates with glycogen via its regulatory β subunit carbohydrate-binding module (CBM). However, the physiological role of AMPK-glycogen binding in energy homeostasis has not been investigated in vivo. This study aimed to determine the physiological consequences of disrupting AMPK-glycogen interactions. Methods: Glycogen binding was disrupted in mice via whole-body knock-in (KI) mutation of either the AMPK β1 (W100A) or β2 (W98A) isoform CBM. Systematic whole-body, tissue and molecular phenotyping was performed in KI and respective wild-type (WT) mice. Results: While β1 W100A KI did not affect whole-body metabolism or exercise capacity, β2 W98A KI mice displayed increased adiposity and impairments in whole-body glucose handling and maximal exercise capacity relative to WT. These KI mutations resulted in reduced total AMPK protein and kinase activity in liver and skeletal muscle of β1 W100A and β2 W98A, respectively, versus WT mice. β1 W100A mice also displayed loss of fasting-induced liver AMPK total and α-specific kinase activation relative to WT. Destabilisation of AMPK was associated with increased fat deposition in β1 W100A liver and β2 W98A skeletal muscle versus WT. Conclusions: These results demonstrate that glycogen binding plays critical roles in stabilising AMPK and maintaining cellular, tissue and whole-body energy homeostasis.
first_indexed 2024-04-13T14:19:55Z
format Article
id doaj.art-87aacaf855cb400a99375db49d1f3201
institution Directory Open Access Journal
issn 2212-8778
language English
last_indexed 2024-04-13T14:19:55Z
publishDate 2020-11-01
publisher Elsevier
record_format Article
series Molecular Metabolism
spelling doaj.art-87aacaf855cb400a99375db49d1f32012022-12-22T02:43:30ZengElsevierMolecular Metabolism2212-87782020-11-0141101048Genetic loss of AMPK-glycogen binding destabilises AMPK and disrupts metabolismNolan J. Hoffman0Jamie Whitfield1Natalie R. Janzen2Mehdi R. Belhaj3Sandra Galic4Lisa Murray-Segal5William J. Smiles6Naomi X.Y. Ling7Toby A. Dite8John W. Scott9Jonathan S. Oakhill10Robert Brink11Bruce E. Kemp12John A. Hawley13Exercise and Nutrition Research Program, Mary MacKillop Institute for Health Research, Australian Catholic University, Level 5, 215 Spring Street, Melbourne, Victoria 3000, Australia; Corresponding author.Exercise and Nutrition Research Program, Mary MacKillop Institute for Health Research, Australian Catholic University, Level 5, 215 Spring Street, Melbourne, Victoria 3000, AustraliaExercise and Nutrition Research Program, Mary MacKillop Institute for Health Research, Australian Catholic University, Level 5, 215 Spring Street, Melbourne, Victoria 3000, AustraliaExercise and Nutrition Research Program, Mary MacKillop Institute for Health Research, Australian Catholic University, Level 5, 215 Spring Street, Melbourne, Victoria 3000, AustraliaSt. Vincent's Institute of Medical Research and Department of Medicine, University of Melbourne, 9 Princes Street, Fitzroy, Victoria 3065, AustraliaSt. Vincent's Institute of Medical Research and Department of Medicine, University of Melbourne, 9 Princes Street, Fitzroy, Victoria 3065, AustraliaSt. Vincent's Institute of Medical Research and Department of Medicine, University of Melbourne, 9 Princes Street, Fitzroy, Victoria 3065, AustraliaSt. Vincent's Institute of Medical Research and Department of Medicine, University of Melbourne, 9 Princes Street, Fitzroy, Victoria 3065, AustraliaSt. Vincent's Institute of Medical Research and Department of Medicine, University of Melbourne, 9 Princes Street, Fitzroy, Victoria 3065, AustraliaExercise and Nutrition Research Program, Mary MacKillop Institute for Health Research, Australian Catholic University, Level 5, 215 Spring Street, Melbourne, Victoria 3000, Australia; St. Vincent's Institute of Medical Research and Department of Medicine, University of Melbourne, 9 Princes Street, Fitzroy, Victoria 3065, Australia; The Florey Institute of Neuroscience and Mental Health, 30 Royal Parade, Parkville, Victoria 3052, AustraliaExercise and Nutrition Research Program, Mary MacKillop Institute for Health Research, Australian Catholic University, Level 5, 215 Spring Street, Melbourne, Victoria 3000, Australia; St. Vincent's Institute of Medical Research and Department of Medicine, University of Melbourne, 9 Princes Street, Fitzroy, Victoria 3065, AustraliaImmunology Division, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, New South Wales 2010, Australia; St. Vincent's Clinical School, UNSW Sydney, Level 5 deLacy Building, St. Vincent's Hospital, Darlinghurst, New South Wales 2010, AustraliaExercise and Nutrition Research Program, Mary MacKillop Institute for Health Research, Australian Catholic University, Level 5, 215 Spring Street, Melbourne, Victoria 3000, Australia; St. Vincent's Institute of Medical Research and Department of Medicine, University of Melbourne, 9 Princes Street, Fitzroy, Victoria 3065, Australia; Corresponding author. St. Vincent's Institute of Medical Research and Department of Medicine, University of Melbourne, 9 Princes Street, Fitzroy, Victoria 3065, Australia.Exercise and Nutrition Research Program, Mary MacKillop Institute for Health Research, Australian Catholic University, Level 5, 215 Spring Street, Melbourne, Victoria 3000, Australia; Corresponding author.Objective: Glycogen is a major energy reserve in liver and skeletal muscle. The master metabolic regulator AMP-activated protein kinase (AMPK) associates with glycogen via its regulatory β subunit carbohydrate-binding module (CBM). However, the physiological role of AMPK-glycogen binding in energy homeostasis has not been investigated in vivo. This study aimed to determine the physiological consequences of disrupting AMPK-glycogen interactions. Methods: Glycogen binding was disrupted in mice via whole-body knock-in (KI) mutation of either the AMPK β1 (W100A) or β2 (W98A) isoform CBM. Systematic whole-body, tissue and molecular phenotyping was performed in KI and respective wild-type (WT) mice. Results: While β1 W100A KI did not affect whole-body metabolism or exercise capacity, β2 W98A KI mice displayed increased adiposity and impairments in whole-body glucose handling and maximal exercise capacity relative to WT. These KI mutations resulted in reduced total AMPK protein and kinase activity in liver and skeletal muscle of β1 W100A and β2 W98A, respectively, versus WT mice. β1 W100A mice also displayed loss of fasting-induced liver AMPK total and α-specific kinase activation relative to WT. Destabilisation of AMPK was associated with increased fat deposition in β1 W100A liver and β2 W98A skeletal muscle versus WT. Conclusions: These results demonstrate that glycogen binding plays critical roles in stabilising AMPK and maintaining cellular, tissue and whole-body energy homeostasis.http://www.sciencedirect.com/science/article/pii/S2212877820301228AMP-activated protein kinaseCarbohydrate-binding moduleCellular energy sensingExerciseLiverSkeletal muscle
spellingShingle Nolan J. Hoffman
Jamie Whitfield
Natalie R. Janzen
Mehdi R. Belhaj
Sandra Galic
Lisa Murray-Segal
William J. Smiles
Naomi X.Y. Ling
Toby A. Dite
John W. Scott
Jonathan S. Oakhill
Robert Brink
Bruce E. Kemp
John A. Hawley
Genetic loss of AMPK-glycogen binding destabilises AMPK and disrupts metabolism
Molecular Metabolism
AMP-activated protein kinase
Carbohydrate-binding module
Cellular energy sensing
Exercise
Liver
Skeletal muscle
title Genetic loss of AMPK-glycogen binding destabilises AMPK and disrupts metabolism
title_full Genetic loss of AMPK-glycogen binding destabilises AMPK and disrupts metabolism
title_fullStr Genetic loss of AMPK-glycogen binding destabilises AMPK and disrupts metabolism
title_full_unstemmed Genetic loss of AMPK-glycogen binding destabilises AMPK and disrupts metabolism
title_short Genetic loss of AMPK-glycogen binding destabilises AMPK and disrupts metabolism
title_sort genetic loss of ampk glycogen binding destabilises ampk and disrupts metabolism
topic AMP-activated protein kinase
Carbohydrate-binding module
Cellular energy sensing
Exercise
Liver
Skeletal muscle
url http://www.sciencedirect.com/science/article/pii/S2212877820301228
work_keys_str_mv AT nolanjhoffman geneticlossofampkglycogenbindingdestabilisesampkanddisruptsmetabolism
AT jamiewhitfield geneticlossofampkglycogenbindingdestabilisesampkanddisruptsmetabolism
AT natalierjanzen geneticlossofampkglycogenbindingdestabilisesampkanddisruptsmetabolism
AT mehdirbelhaj geneticlossofampkglycogenbindingdestabilisesampkanddisruptsmetabolism
AT sandragalic geneticlossofampkglycogenbindingdestabilisesampkanddisruptsmetabolism
AT lisamurraysegal geneticlossofampkglycogenbindingdestabilisesampkanddisruptsmetabolism
AT williamjsmiles geneticlossofampkglycogenbindingdestabilisesampkanddisruptsmetabolism
AT naomixyling geneticlossofampkglycogenbindingdestabilisesampkanddisruptsmetabolism
AT tobyadite geneticlossofampkglycogenbindingdestabilisesampkanddisruptsmetabolism
AT johnwscott geneticlossofampkglycogenbindingdestabilisesampkanddisruptsmetabolism
AT jonathansoakhill geneticlossofampkglycogenbindingdestabilisesampkanddisruptsmetabolism
AT robertbrink geneticlossofampkglycogenbindingdestabilisesampkanddisruptsmetabolism
AT bruceekemp geneticlossofampkglycogenbindingdestabilisesampkanddisruptsmetabolism
AT johnahawley geneticlossofampkglycogenbindingdestabilisesampkanddisruptsmetabolism